Dr. Pablo Serrano, MD, MPH, MSc
Claim this profileHamilton Health Sciences - Juravinski Hospital
Studies Aortic Paravalvular Leaks
Studies Anastomotic Leak
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Pablo Serrano, MD, MPH, MSc is currently running
PERT
for Pancreatic Insufficiency
After pancreas surgery, patients may develop pancreatic exocrine insufficiency (PEI). PEI can be treated with oral pancreatic enzyme replacement therapy (PERT). However, the diagnosis of PEI is difficult and the guidelines about when to start PERT after pancreas surgery are conflicting. This pilot study aims to determine the feasibility of implementing a large-scale clinical trial to definitively evaluate if starting PERT immediately after surgery can improve outcomes in patients undergoing pancreas surgery.
Recruiting1 award N/A
Stream™ Platform
for Detecting Anastomotic Leak
This Economic Evaluation study is a multi-center, two-arm, non-randomized, interventional trial. The purpose of this study is to evaluate the economic and patient outcomes of using the Stream™ Platform for early detection of anastomotic leakage after gastrointestinal surgery. The trial will track patient outcomes and healthcare costs in two groups: the intervention group, where the Stream platform is deployed, and the control group, before the integration of the Stream™ Platform. The data collected from both groups will be compared to assess the impact of implementing the Stream™ Platform and early leak detection on overall patient outcomes and healthcare costs.This trial will include hepatobiliary, colorectal, and trauma/acute care patient populations.
Recruiting1 award Phase 3
More about Pablo Serrano, MD, MPH, MSc
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Pablo Serrano, MD, MPH, MSc has experience with
- Cefoxitin
- Piperacillin-tazobactam
- Intraoperative Incisional Wound Irrigation With Povidone-iodine Solution
- Intraoperative Incisional Wound Irrigation With Saline
- PERT
- NERv's Inline Device
Breakdown of trials Pablo Serrano, MD, MPH, MSc has run
Aortic Paravalvular Leaks
Anastomotic Leak
Pancreatic Dysplasia
Pancreatic Cancer
Pancreatic Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pablo Serrano, MD, MPH, MSc specialize in?
Pablo Serrano, MD, MPH, MSc focuses on Aortic Paravalvular Leaks and Anastomotic Leak. In particular, much of their work with Aortic Paravalvular Leaks has involved treating patients, or patients who are undergoing treatment.
Is Pablo Serrano, MD, MPH, MSc currently recruiting for clinical trials?
Yes, Pablo Serrano, MD, MPH, MSc is currently recruiting for 3 clinical trials in Hamilton Ontrario. If you're interested in participating, you should apply.
Are there any treatments that Pablo Serrano, MD, MPH, MSc has studied deeply?
Yes, Pablo Serrano, MD, MPH, MSc has studied treatments such as Cefoxitin, Piperacillin-tazobactam, Intraoperative incisional wound irrigation with povidone-iodine solution.
What is the best way to schedule an appointment with Pablo Serrano, MD, MPH, MSc?
Apply for one of the trials that Pablo Serrano, MD, MPH, MSc is conducting.
What is the office address of Pablo Serrano, MD, MPH, MSc?
The office of Pablo Serrano, MD, MPH, MSc is located at: Juravinski Hospital- Hamilton Health Sciences, Hamilton, Ontrario L8V 1C3 Canada. This is the address for their practice at the Juravinski Hospital- Hamilton Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.